|
|
|
|
| LEADER |
01517nam a22002777i 4500 |
| 007 |
ta |
| 008 |
130914e1980 us ||||gr|||| 00| 0 eng d |
| 020 |
|
|
|a 0812106814
|
| 040 |
|
|
|a Sistema Bibliotecario Universidad de El Salvador
|b spa
|
| 041 |
|
|
|a eng
|
| 082 |
|
|
|a 615.7
|b R883c
|
| 100 |
1 |
|
|a Rowland, Malcolm
|
| 245 |
1 |
0 |
|a Clinical pharmacokinetics: concepts and applications /
|c Malcolm Rowland, Thomas N. Tozer
|
| 264 |
|
|
|a Philadelphia :
|b Lea & Febiger,
|c 1980
|
| 300 |
|
|
|a 331 páginas :
|b gráficas ;
|c 25 cm
|
| 336 |
|
|
|2 rdacontent
|a texto
|b txt
|
| 337 |
|
|
|2 rdamedia
|a no mediado
|b n
|
| 338 |
|
|
|2 rdacarrier
|a volumen
|b nc
|
| 500 |
|
|
|a Incluye Apéndices--Indice
|
| 505 |
|
|
|a Why clinical pharmacokinectics?--Concepts: Basic considerations, Absorption, Distribution, Clearance and renal excretion, Hepatic clearance and elimination.--Disposition and absorption kinetics: Intravevous dose, Constant rate entravenous infusion, Extravascular dose, Metabolite kinetics, Integration of concepts and kinetics.--Therapeutic regimens: Therapeutic response and toxicity, Dosage regimens.--Individualization: variability in drug response, Age and weight, Renal function impairment, Drug interactions, Monitoring drug therapy.
|
| 650 |
|
7 |
|2 LEMB
|a Farmacocinética
|
| 650 |
|
7 |
|2 lemb
|a Farmacología
|
| 700 |
1 |
|
|a Tozer, Thomas N.
|e autor
|
| 942 |
|
|
|2 ddc
|c BK
|
| 999 |
|
|
|c 33580
|d 33580
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_R883C
|7 0
|8 CG
|9 48315
|a 16
|b 16
|c CG
|d 1989-09-14
|o 615.7 R883c
|p 16004091
|r 2013-09-14
|t 1
|w 2013-09-14
|y BK
|